$125 | Single User
$250 | Site License
$375 | Global License

Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review [Report Updated: 25-04-2018]

Published by Global Data: 25 Apr 2018 | 208526 | In Stock

Introduction

Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – GlobalData’s summarization of the company’s business strategy.

- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Urigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and commercializes therapeutic products for urological disorders. The company focuses on developing innovative products for amelioration of urethritis, painful bladder syndrome (PBS), nocturia and over active bladder (OAB). Its pipeline includes its flagship candidate, URG101, being developed for the painful bladder syndrome/interstitial cystitis. The company licensed URG101, is a proprietary combination therapy for the relief of pain of bladder. Its other product candidate, URG501, is in pre-clinical development. Urigen is headquartered in North Brunswick, New Jersey, the US.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review [Report Updated: 25-04-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Section 1 - About the Company 5

    Urigen Pharmaceuticals Inc - Key Facts 5

    Urigen Pharmaceuticals Inc - Key Employees 6

    Urigen Pharmaceuticals Inc - Key Employee Biographies 7

    Urigen Pharmaceuticals Inc - Major Products and Services 8

    Urigen Pharmaceuticals Inc - History 9

    Urigen Pharmaceuticals Inc - Locations And Subsidiaries 11

    Head Office 11

    Section 2 – Company Analysis 12

    Company Overview 12

    Urigen Pharmaceuticals Inc - Business Description 12

    Urigen Pharmaceuticals Inc - SWOT Analysis 13

    SWOT Analysis - Overview 13

    Urigen Pharmaceuticals Inc - Strengths 13

    Urigen Pharmaceuticals Inc - Weaknesses 14

    Urigen Pharmaceuticals Inc - Opportunities 15

    Urigen Pharmaceuticals Inc - Threats 16

    Urigen Pharmaceuticals Inc - Key Competitors 17

    Section 3 – Company’s Lifesciences Financial Deals and Alliances 18

    Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18

    Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 19

    Urigen Pharmaceuticals Inc, Recent Deals Summary 20

    Section 4 – Appendix 21

    Methodology 21

    About GlobalData 21

    Contact Us 21

    Disclaimer 21

List Of Tables
in Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review [Report Updated: 25-04-2018]

List of Tables

Urigen Pharmaceuticals Inc, Key Facts 5

Urigen Pharmaceuticals Inc, Key Employees 6

Urigen Pharmaceuticals Inc, Key Employee Biographies 7

Urigen Pharmaceuticals Inc, Major Products and Services 8

Urigen Pharmaceuticals Inc, History 9

Urigen Pharmaceuticals Inc, Key Competitors 17

Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18

Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 19

Urigen Pharmaceuticals Inc, Recent Deals Summary 20

List Of Figures, Charts and Diagrams
in Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review [Report Updated: 25-04-2018]

List of Figures

Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18

Urigen Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 19

Additional Details

Publisher

Global Data

Publisher Information

Reference

208526 | GDPH81671SA

Number of Pages

21

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Urigen Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUrigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and c...
13 Nov 2018 by Global Data USD $250 More Info
Urigen Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUrigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and c...
06 Jul 2018 by Global Data USD $250 More Info
Urigen Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUrigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and c...
25 Apr 2018 by Global Data USD $250 More Info
Urigen Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUrigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and c...
19 Feb 2018 by Global Data USD $250 More Info
Urigen Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUrigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and c...
08 Nov 2017 by Global Data USD $250 More Info
Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review
Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into th...
07 Nov 2017 by Global Data USD $125 More Info
Urigen Pharmaceuticals Inc (URGP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUrigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and c...
17 May 2017 by Global Data USD $250 More Info
Urigen Pharmaceuticals Inc (URGP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUrigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and c...
22 Mar 2017 by Global Data USD $250 More Info
Urigen Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUrigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and c...
28 Nov 2016 by Global Data USD $250 More Info
Urigen Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Urigen Pharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into ...
26 Jul 2016 by Global Data USD $125 More Info

This report is published by Global Data

Download Free Report Summary PDF

Urigen Pharmaceuticals Inc - Strategic SWOT Analysis Review [Report Updated: 25-04-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data